Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
Di Maio
Massimo
M
Daniele
Bruno
B
Gallo
Ciro
C
Perrone
Francesco
F
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D002986:Clinical Trials as Topic / Q000379:methods*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D023381:Endpoint Determination; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D009367:Neoplasm Staging; D018579:Patient Selection; D012107:Research Design